Contra Avi Genomic Medicine Inc.
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$0.15avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Contra Avi Genomic Medicine Inc. in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Verity Asset Management, Inc. ($4K).
- Company
- Contra Avi Genomic Medicine Inc.
- CUSIP
- 008CVR011
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Verity Asset Management, Inc. | 0.00% | No change | 30,500 | $4K |
"% of holder's portfolio" is CONTRA AVI GENOMIC MEDICINE INC's weight in each manager's 13F, not the share of Contra Avi Genomic Medicine Inc. the manager owns.